An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments

References

• DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther 2006;13:161–5.
   PubMedGoogle Scholar
• Nelson L. Acute cyanide toxicity: mechanisms and manifestations. J Emerg Nurs 2006;32:S8–11.
   PubMed Web of Science ®Google Scholar
• Borron SW. Recognition and treatment of acute cyanide poisoning. J Emerg Nurs 2006;32:S12–S18.
   PubMed Web of Science ®Google Scholar
• Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med 2001;37:635–41.
   PubMed Web of Science ®Google Scholar
• Moore SJ, Norris JC, Walsh DA, Hume AS. Antidotal use of methemoglobin forming cyanide antagonists in concurrent carbon monoxide/cyanide intoxication. J Pharmacol Exp Ther 1987;242:70–3.
   PubMed Web of Science ®Google Scholar
• Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31:277–94.
   PubMed Web of Science ®Google Scholar
• Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila) 2006;44 (Suppl. 1):17–28.
   PubMedGoogle Scholar
• Merck Santé s.a.s. Cyanokit Cyanokit summary of product characteristics. European Medicines Agency H806, 23 November 2007.
   Google Scholar
• Hall AH, Saiers J, Baud F. Which cyanide antidote? Crit Rev Toxicol 2009;39:541–52.
   PubMed Web of Science ®Google Scholar
• Borron SW, Baud FJ, Megarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 2007;25:551–8.
   PubMed Web of Science ®Google Scholar
• Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila) 2006; 44(Suppl. 1):37–44.
   PubMedGoogle Scholar
• Cescon DW, Juurlink DN. Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning. CMAJ 2009;180:251.
   PubMed Web of Science ®Google Scholar
• Curry SC, Connor DA, Raschke RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994;24:65–7.
   PubMed Web of Science ®Google Scholar
• Gourlain H, Caliez C, Laforge M, Buneaux F, Levillain P. Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters. Ann Biol Clin (Paris) 1994;52:121–4.
   PubMed Web of Science ®Google Scholar
• Pamidi PV, DeAbreu M, Kim D, Mansouri S. Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta 2009; 401:63–7.
   PubMed Web of Science ®Google Scholar
• Lee J, Mukai D, Kreuter K, Mahon S, Tromberg B, Brenner M. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med 2007;49: 802–5.
   PubMed Web of Science ®Google Scholar
• Vest P, Renaudeau C, Tellal S, Ragot C, Renard C. [Interference of hydroxocobalamine treatment on commun biochemical determinations]. Ann Biol Clin (Paris) 2002;60: 57–64.
   PubMed Web of Science ®Google Scholar
• Baud FJ, Borron SW, Megarbane B, Trout H, Lapostolle F, Vicaut E, Debray M, Bismuth C. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med 2002;30:2044–50.
   PubMed Web of Science ®Google Scholar
• McEnroe RJ. Interference testing in clinical chemistry; Approved Guideline. Second, 23 November 2005. Clinical and Laboratory Standards Institute. CLSI document EP7-A2.
   Google Scholar
• Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986;32:470–5.
   PubMed Web of Science ®Google Scholar
• Vermeer HJ, Thomassen E, de JN. Automated processing of serum indices used for interference detection by the laboratory information system. Clin Chem 2005;51:244–7.
   PubMed Web of Science ®Google Scholar
• Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007; 49:794–801.
   PubMed Web of Science ®Google Scholar
• Baud F. Clarifications regarding interference of hydroxocobalamin with carboxyhemoglobin measurements in victims of smoke inhalation. Ann Emerg Med 2007;50: 625–6.
   PubMed Web of Science ®Google Scholar
• Schrauzer GN, Lee LP. Cobaloximes(II) and vitamin B12r as oxygen carriers. Evidence for monomeric and dimeric peroxides and superoxides. J Am Chem Soc 1970; 92:1551–7.
   PubMed Web of Science ®Google Scholar
• Schrauzer GN. New developments in the field of vitamin B12: reactions of the cobalt atom in corrins and in vitamin B12 model compounds. Angew Chem Int Ed Engl 1976; 15:417–26.
   PubMed Web of Science ®Google Scholar
• Garau G, Geremia S, Marzilli LG, Nardin G, Randaccio L, Tauzher G. Crystal chemistry and binding of NO2, SCN and SeCN to Co in cobalamins. Acta Crystallogr B 2003; 59:51–9.
   PubMedGoogle Scholar
• Uhl W, Nolting A, Gallemann D, Hecht S, Kovar A. Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers. Clin Toxicol (Phila) 2008;46:551–9.
   PubMed Web of Science ®Google Scholar